Fosquel®
Fosquel® is indicated for the control of hyperphosphatemia in adult patients receiving hemodialysis or peritoneal dialysis, in adult patients with chronic kidney disease (CKD) who are not on dialysis with a serum phosphorus level ≥ 1.78 mmol/l, and in pediatric patients (> 6 years of age and with a body surface area (BSA) > 0.75 m2) with chronic kidney disease.
Fosquel® should be used in the context of a multiple therapeutic approach, which could include calcium supplementation, 1,25 di-hydroxy vitamin D3 or one of its analogs to control the development of renal bone disease.
Access technical file Fosquel® 800 mg film-coated tablets Access technical file Fosquel® 2.4 g powder for oral suspension
Fosquel®
Last update: July 2024
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.